Marçal Pastor-Anglada
Jefe de Grupo Senior
Research group
Dr. Marçal Pastor-Anglada graduated in Biology in 1980 and obtained his PhD in Biochemistry in 1985 from the University of Barcelona. From 1984 to 1986 he was an INSERM researcher at the CNRS Recherches sur l'Endocrinologie Moléculaire et le Developpement in Meudon-Bellevue (France). From 1989 to 1990 he was a Research Associate at the Department of Cellular, Molecular and Developmental Biology at the University of California, Santa Barbara (UCSB) (USA) and later (1997) Visiting Associate Professor at the McArdle Laboratory for Cancer Research, Department of Oncology, School of Medicine, University of Wisconsin-Madison (USA). In 2007, he was Visiting Professor at the Molecular and Cellular Physiology Laboratory, School of Medicine, Pontifical Catholic University of Chile, Santiago (Chile).
Since 2003 he has been Professor of Biochemistry and Molecular Biology at the University of Barcelona. He is Principal Investigator of the Molecular Pharmacology and Experimental Therapies group, also a member of the Cell Plasticity and Metabolism Program of the Institute of Biomedicine of the University of Barcelona (IBUB) and of the Program of Hepatic and Digestive Oncology of the CIBER EHD. In addition to his research work, Dr. Pastor-Anglada has solid experience in R&D management, currently being Director of IBUB.
Professional network profiles
Last Publications
- Camarero-Hoyos C, Bouzón-Arnáiz I, Avalos-Padilla Y, Fallica AN, Román-Álamo L, Ramírez M, Portabella E, Cuspinera O, Currea-Ayala D, Orozco-Quer M, Ribera M, Siden-Kiamos I, Spanos L, Iglesias V, Crespo B, Viera S, Andreu D, Sulleiro E, Zarzuela F, Urtasun N, Perez-Torras S, Pastor-Anglada M, Arce EM, Muñoz-Torrero D and Fernàndez-Busquets X Leveraging the Aggregated Protein Dye YAT2150 for Malaria Chemotherapy. Pharmaceutics . 16(10): .
- Mata A, Vila-Planas A, Solsona-Pujol A, Dueña J, Torrents M, Izquierdo-García E, Pastor-Anglada M, Perez-Torras S and Terrazas M RNase H-sensitive multifunctional ASO-based constructs as promising tools for the treatment of multifactorial complex pathologies. BIOORG CHEM . 150: 107595-107595.
- Pena-Rodriguez, E, García-Vega L, Lajarin Reinares M, Pastor-Anglada M, Perez-Torras S and Fernandez-Campos, F Latanoprost-Loaded Nanotransfersomes Designed for Scalp Administration Enhance Keratinocytes Proliferation MOLECULAR PHARMACEUTICS . 20(5): 2317-2325.
News
-
A drug capable of simultaneously targeting three different therapeutic targets is designed.
The study, published in the journal Bioorganic Chemistry, presents a proof of concept for this innovative triple-effect compound, which has been successfully applied to breast cancer cells. According to experts, this therapy has "high potential for the treatment of complex diseases such as cancer or diabetes.
More activities
-
Cátedra UB de Enfermedades Raras: Jornada sobre la Investigación
Aula de Graus. Facultat de Biologia. Universitat de Barcelona